Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Shanghai - Delayed Quote CNY

Zhejiang Jiuzhou Pharmaceutical Co., Ltd (603456.SS)

13.86
-0.01
(-0.07%)
At close: 3:00:01 PM GMT+8

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.
NameTitlePayExercisedYear Born
Mr. Yi Jiang Mei President & Director -- -- 1975
Mr. Yujie Sha VP, Financial Director & Director -- -- 1981
Mr. Huilu Lin VP, Secretary of the Board of Directors & Director -- -- 1974
Dr. Yuanqiang Li VP & Director -- -- 1968
Mr. Nonggang Yang Vice President -- -- 1975
Ms. Minxia Huang Vice President -- -- 1976
Mr. Gong Chen Vice President -- -- 1982

Zhejiang Jiuzhou Pharmaceutical Co., Ltd

No. 99 Waisha Road
Jiaojiang District
Taizhou, 318000
China
https://www.jiuzhoupharma.com
Sector: 
Healthcare
Full Time Employees: 
5,001

Description

Zhejiang Jiuzhou Pharmaceutical Co., Ltd operates as contract development and manufacturing organization company in China and internationally. The company offers small molecule chemical drugs, peptide drugs, conjugated drugs, and small nucleic acid drugs. It serves global pharmaceutical companies, biotechnology companies, and research institutions. Zhejiang Jiuzhou Pharmaceutical Co., Ltd was founded in 1973 and is headquartered in Taizhou, China.

Corporate Governance

Zhejiang Jiuzhou Pharmaceutical Co., Ltd’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

April 15, 2025 at 10:59 AM UTC

Zhejiang Jiuzhou Pharmaceutical Co., Ltd Earnings Date

Recent Events

July 4, 2024 at 12:00 AM UTC

Ex-Dividend Date